NCT04281992View on ClinicalTrials.gov

Treatment of Diabetic Foot Ulcers With AUP1602-C

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 28, 2020

Primary Completion Date

March 20, 2023

Study Completion Date

March 20, 2023

Conditions
Diabetic Foot Ulcer
Interventions
BIOLOGICAL

AUP1602-C

AUP1602-C is topically applied on chronic wounds and covered by wound dressing.

Trial Locations (2)

Unknown

Medizinische Hochschule Hannover (MHH) CRC Core Facility, Hanover

Mikomed, Lodz

All Listed Sponsors
lead

Aurealis Oy

INDUSTRY

NCT04281992 - Treatment of Diabetic Foot Ulcers With AUP1602-C | Biotech Hunter | Biotech Hunter